✦ LIBER ✦

Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study

✍ Scribed by Dominique Koensgen; Guelten Oskay-Oezcelik; Ioanna Katsares; Ulla Walle; Christine Klapp; Alexander Mustea; Dirk Stengel; Franz Porzsolt; Werner Lichtenegger; Jalid Sehouli; on behalf of the Nord-Ostdeutschen Gesellschaft für Gynäkologische Onkologie (NOGGO) working group “Quality of life”

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 252 KB
Volume: 18
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-009-0733-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan and carboplatin in patients wi

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

✍ Dominique Koensgen; Dirk Stengel; Antje Belau; Peter Klare; Guelten Oskay-Oezcel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 324 KB

Weekly paclitaxel and carboplatin (PC-W)

Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO

✍ Jalid Sehouli; Dirk Stengel; Alexander Mustea; Oumar Camara; Elke Keil; Dirk Ell 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 368 KB

Interferon-α and chemohormonal therapy f

Interferon-α and chemohormonal therapy for patients with advanced melanoma : Final results of a Phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program

✍ James J. Stark; Robert O. Dillman; Richard Schulof; Michael C. Wiemann; Neil M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Background: The treatment of metastatic melanoma remains unsatisfactory despite encouraging results with biotherapy and combination chemotherapy. combining these two modalities may improve outcomes for such patients. ## Methods: Patients who were eligible for this study had metastatic melanoma